You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 46 No. 3, March 1943 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

DEMEROL

A SUBSTITUTE FOR MORPHINE IN THE TREATMENT OF POSTOPERATIVE PAIN

ROBERT C. BATTERMAN, M.D.; LIEUTENANT COLONEL JOHN H. MULHOLLAND

Arch Surg. 1943;46(3):404-409.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It is the purpose of this paper to present in greater detail a report of the effectiveness of demerol, a new synthetic analgesic, for the control of postoperative pain and restlessness. A complete discussion1 of the properties of the drug, including its effectiveness, safety and potency in the treatment of a large variety of conditions, has already been presented by one of us (R. C. B.).

Demerol2 (1-methyl-4-phenyl-piperidine-4-carboxylic acid ethyl ester hydrochloride) was introduced by Eisleb and Schaumann3 in 1939 and was almost immediately acclaimed by numerous investigators4 as a potent and safe analgesic approaching morphine in effectiveness. Its advantages, especially its antispasmodic properties, soon became apparent. Thus the atropine-like effect combined with sedative action makes it an ideal drug for the treatment of severe colicky pain. With exception of rare hypersensitive persons, demerol may be used without contraindication in patients with severe anemia, disease of . . . [Full Text PDF of this Article]


Author Affiliations

NEW YORK

From the Departments of Therapeutics and Surgery, New York University College of Medicine, and the Third Surgical Division (New York University), Bellevue Hospital.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1943 American Medical Association. All Rights Reserved.